Physician
Rakowska, Urszula
Rakowska, Urszula was paid $1.90M by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoRAKOWSKA, URSZULA
LINDENHURST, NY 11757
LINDENHURST, NY 11757
33aNPI1952415630assigned 08/18/2006
33bProvider typePediatrics Physician
28Total paid$1.90M
24GClaims87,791
24DCodes billed47
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#175 of 1,983
Median peer was paid$17K
This provider vs. median112×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,292 | $401K | |
| 2019 | 24,030 | $494K | |
| 2020 | 23,493 | $479K | |
| 2021 | 18,203 | $426K | |
| 2022 | 2,557 | $45K | |
| 2023 | 1,617 | $37K | |
| 2024incomplete | 599 | $18K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 13,081 | 10,993 | $633K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 16% | 8,424 | 8,299 | $313K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.7% | 2,433 | 2,270 | $165K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.4% | 2,118 | 2,105 | $141K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.9% | 1,761 | 1,754 | $131K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.4% | 1,495 | 1,493 | $103K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.5% | 1,400 | 1,359 | $86K |
| 99051 | 3.1% | 9,168 | 8,120 | $58K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.9% | 1,535 | 1,489 | $54K |
| 92553 | 2.1% | 1,565 | 1,554 | $40K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.0% | 1,807 | 1,702 | $38K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 4,075 | 3,740 | $28K |
35 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 1,079 | $27K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,384 | $14K |
| 86580 | <1% | 2,192 | $12K | |
| 81002 | <1% | 4,724 | $9K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 112 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,634 | $8K |
| 99173 | <1% | 4,105 | $6K | |
| 90461 | <1% | 231 | $6K | |
| 96127 | <1% | 1,295 | $5K | |
| 90621 | <1% | 153 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 196 | $2K |
| 81000 | <1% | 862 | $2K | |
| 90651 | <1% | 229 | $2K | |
| 90686 | <1% | 805 | $1K | |
| 69210 | <1% | 28 | $488.23 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $476.23 |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 198 | $359.25 |
| 90744 | <1% | 241 | $227.33 | |
| 90734 | <1% | 119 | $196.21 | |
| 99000 | <1% | 8,685 | $154.70 | |
| 90716 | <1% | 27 | $150.00 | |
| 96160 | <1% | 74 | $137.31 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 18 | $78.70 |
| 90715 | <1% | 28 | $77.50 | |
| 90670 | <1% | 81 | $53.55 | |
| 90713 | <1% | 278 | $26.82 | |
| 94760 | <1% | 2,077 | $15.14 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 148 | $6.88 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 173 | $5.95 |
| 90700 | 0% | 402 | $0.00 | |
| 90648 | 0% | 155 | $0.00 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 69 | $0.00 |
| 90685 | 0% | 14 | $0.00 | |
| 90707 | 0% | 25 | $0.00 | |
| 90619 | 0% | 58 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.